To ensure the critical objective of ‘Patient Safety First’, Aspin Pharma enforces compliance to Good Pharmacovigilance practices, adhering to applicable local and global regulations, via robust reporting, monitoring and tracking system.

For any Suspected Adverse Event or Product complaint related to our marketed brands, you may contact:

Drug Safety
https://aspin.com.pk/wp-content/uploads/2019/09/email.png
Email:
drugsafety@aspin.com.pk
products.complaints@aspin.com.pk
https://aspin.com.pk/wp-content/uploads/2019/09/phone.png
Primary: +92 300 0806261
Secondary: +92 30047750
Office: +92 213504 5560-62